Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-02

FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved a supplemental application for abiraterone acetate (ABIRATERONE) from Amneal Pharmaceuticals NY LLC, authorizing changes to the product's appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE)